Rossari Biotech

SpiceJet, MOIL: 5 buzzing stocks that may gain up to 19% in short-term

Among the most buzzing stocks, Spicejet surged 18 per cent. MOIL soared close to 9 per cent, while eClerx Services, Brigade Enterprises and Rossari Biotech were trading with 5-6 per cent gains

Rossari Biotech tanks 20%, hits 52-week low post December quarter results

The management said raw material volatility has impacted profitability performance during the quarter

Rossari Biotech hikes prices, sees 50% jump in revenue, profit this fiscal

Rossari Biotech is expecting to close FY'22 with at least 50 per cent growth in both topline and bottomline on the back of rising demand and a substantial price hike that will help boost margins

Rossari to acquire Tristar Intermediates at enterprise value of Rs 120 cr

Rossari Biotech Ltd, a speciality chemicals manufacturer, on Sunday announced the acquisition of Tristar Intermediates at an enterprise value of Rs 120 crore. The board of the company has approved the acquisition of Tristar Intermediates, a move which will help Rossari Biotech expand its product portfolio, primarily in the personal care segment, a joint statement said. As per the agreement and subject to customary closing conditions, Rossari will be acquiring 100 per cent equity share capital of Tristar Intermediates, it added. "76 per cent of the equity share capital will be acquired upon closure of the transaction, and the balance 24% over the next three years. The total enterprise value of the transaction is Rs 120 crore," it said. Rossari plans to fund the investment through cash on the balance sheet and doesn't intend to raise any debt for this acquisition. Established in 1998, Tristar Intermediates operates in the field of Preservatives, Aroma Chemicals, and Home & Personal

Stocks to watch: Rossari Biotech, Tata Power, RIL, Ruchi Soya, sugar stocks

Gujarat State Petronet, APL Apollo Tubes, Arvind Fashions, Nucleus Software Exports and Quess Corp are among 29 companies slated to post their quarterly numbers today

Chemical firm Rossari Biotech to acquire Unitop Chemicals for Rs 421 crore

Speciality-Chemicals manufacturer Rossari Biotech on Wednesday announced the acquisition of Unitop Chemicals, a supplier of surfactants, emulsifiers, and specialty chemicals, for Rs 421 crore.

Rossari Biotech posts 37% revenue growth in Q4 at Rs 218 crore

Rossari Biotech has posted 37 per cent increase in its revenues from operations during the quarter ended March at Rs 218 crore as against Rs 160 crore in the year-ago period

Rossari Biotech shares surge 9%, hit highest level since listing

Thus far in the month of April, the stock has soared 16 per cent in four trading days, after the company announced full commissioning of its Greenfield manufacturing facility at Dahej, Gujarat

Rossari Biotech IPO: A diversified portfolio, expansion are key triggers

The expansion is expected to support growth with revenues and profits estimated to rise by 20-25 per cent over the FY20-23 period

Rossari Biotech slips 5% after board approves Rs 300 cr preferential issue

Rossari proposes to utilise the net proceeds to evaluate and invest in inorganic growth opportunities, within its core chemistries, with a view to diversify its product portfolio

Rossari Biotech stock advances 11% to hit new high since listing

In the past one month, the stock has outperformed the market by gaining 25 per cent, as compared to a 7.5 per cent rise in the S&P BSE Sensex.

Street signs: Sebi NAV rule, more bumper listings on the cards, and more

Market players believe the new Sebi rule on net asset values (NAVs) will help capture the transactions on both asset and liability sides without any lag

Rossari Biotech surges 18% in 2 days after Plutus Wealth acquires stake

The stock was trading at its highest level since its listing on July 23, 2020

September may see end of one-month IPO drought with five hitting the market

Despite supportive markets, August saw no new offerings

Rossari Biotech shares soar 75% on debut on the back of huge demand

The last company to list following an IPO was SBI Cards on March 16

Top headlines: BPCL bidding extended, Flipkart acquires Walmart India

Here are the top headlines of the day

Rossari Biotech makes strong debut; share price jumps 64% over issue price

The stock rallied 64% to Rs 698 against issue price of Rs 425 on the BSE.